cjc-1295 ipamorelin benefits side effects igf-1 levels anti-aging IPA/CJC/IGF BLEND CJC-1295 vs Ipamorelin vs Sermorelin
Description
1999 May;81(5):535-8
doi: 10.3389/fonc.2020.593017 36 DograSNeelakantanDPatelMMGrieselBOlsonAWooS
Gholami L
The frequently altered phosphoinositide-3 kinase/protein kinase B/mammalian target of rapamycin (PI3K/AKT/mTOR) axis, which regulates tumor growth and survival, is a promising therapeutic target, although clinical trials of mTOR inhibitors have shown limited success
doi: 10.1016/j.biopha.2022.113810 58 MacchioneI
